Skip to main content
Caplight Logo









MyBliss

MyBliss

Private
LondonConsumer & Commercehttps://my-bliss.co.uk

Last Round

Seed

Dec 2, 2025

Total Funding Raised

$120,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MyBliss operates in Consumer & Commerce and is based in London. Its latest recorded funding round was a Seed round in December 2025.

MyBliss is a medical supplies company that provides intimate wellness products formulated to protect vaginal balance, including ultra-thin condoms, pH-balanced lubricants, and dermatologist-tested balms.

Sector

Consumer & Commerce

Verticals

D2C Brands, E-commerce, Subscription Commerce, Medical Devices

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MyBliss Comparables

Compare MyBliss with similar companies based on industry and business-model similarity.

MyBliss comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hanx
89%
Lovability
79%
Here We Flo
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MyBliss Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 2, 2025
GrantAug 1, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

MyBliss Investors

Notable investors and investment history

MyBliss investors
InvestorRounds
Lifted VenturesSeed
Alma AngelsSeed
Innovate UKGrant
Mint VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 100% MoM, reaching 6.4K.

  • Jul 27, 2026

    Monthly visitors increased 61% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

MyBliss Filings

Explore SEC and related filing metadata, where available.

MyBliss filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MyBliss's valuation, stock price, and market status.

Is MyBliss a public or private company?

MyBliss is a private company.

What is the current stock price of MyBliss?

MyBliss is a private company, so its shares have no public market price. Caplight tracks MyBliss's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MyBliss worth (valuation)?

Valuation information for MyBliss is not publicly available.

Can I buy MyBliss stock?

MyBliss shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MyBliss's last funding round?

MyBliss's most recent funding round was Seed on December 2, 2025.

Who are the main investors in MyBliss?

Key investors in MyBliss include Mint Ventures.

Will MyBliss IPO soon?

No public IPO plans have been announced for MyBliss.

How can I track MyBliss secondary market activity?

Caplight tracks bids, offers, and trades in MyBliss's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range3
Year Founded2021
Last FundingDec 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?